- active not recruitingPHASE3
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
This study looks at whether Olaparib tablets can help women with advanced ovarian cancer that has a specific genetic change (BRCA mutation) after their initial chemotherapy, aiming to keep the cancer from returning for longer.
United States · Australia · Brazil - recruitingPHASE1
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
This study is testing a new medicine called MOv18 IgE for women with advanced ovarian, endometrial, or triple-negative breast cancer. It aims to find a safe dose and see how well it works, especially in cancers that have a specific marker called Folate Receptor Alpha.
United Kingdom